Brief: Rain Therapeutics Reports First Quarter 2022 Financial Results
04/05/2022 23:01
May 4 (Reuters) - Rain Therapeutics Inc RAIN.O :
* RAIN THERAPEUTICS REPORTS FIRST QUARTER 2022 FINANCIAL
RESULTS
AND HIGHLIGHTS RECENT PROGRESS
* QUARTER-END CASH POSITION OF $123.2 MILLION PROVIDES AMPLE
CASH
RUNWAY INTO FIRST HALF OF 2024
* QTRLY NET LOSS PER SHARE, BASIC AND DILUTED $0.66
* Q1 EARNINGS PER SHARE VIEW $-0.70 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNXbMkljf
Further company coverage: RAIN.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Rain Oncology
See all newsBrief: Rain Enhancement Technologies Holdco - May Offer Up To $25 Million In Securities From Time To Time - SEC Filing
Brief: Rain Enhancement Technologies Holdco Inc - Q1 And Q2 2025 Financial Statements Should Not Be Relied Upon Due To Accounting Error - SEC Filing
Brief: Rain Oncology Pursuant To Proposed Deal With Pathos AI
Brief: Rain Oncology To Be Acquired By Pathos AI For $1.16 In Cash Per Share Plus Contingent Value Rights
Brief: Rain Oncology Q3 Net Income USD -7.034 Million